H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Novartis Institutes for BioMedical Research, Inc. | 3 | $117,416 | $111,509 - $120,078 | 100.0% |
| Schrodinger Inc. | 2 | $119,925 | $117,000 - $122,850 | 100.0% |
| IGM Autoimmunity and Inflammation, Inc | 2 | $130,000 | $130,000 - $130,000 | 100.0% |
| Carmine Therapeutics, Inc. | 2 | $112,220 | $97,000 - $127,440 | 50.0% |
| Lyterian Therapeutics | 1 | $142,700 | $142,700 - $142,700 | 100.0% |
| Takeda Development Center Americas, Inc. | 1 | $145,000 | $145,000 - $145,000 | 100.0% |
| AMADOR BIOSCIENCE INC | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| VOR BIOPHARMA, INC. | 1 | $120,000 | $120,000 - $120,000 | 100.0% |
| AstraZeneca Pharmacetuicals LP | 1 | $113,308 | $113,308 - $113,308 | 100.0% |
| Civetta Therapeutics, LLC | 1 | $118,500 | $118,500 - $118,500 | 100.0% |
| DANAFARBER CANCER INSTITUTE | 1 | $95,000 | $95,000 - $95,000 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| II | 16 | $120,000 | $95,000 - $145,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Emeryville | CA | 3 | $117,416 |
| New York | NY | 2 | $119,925 |
| North Cambridge | MA | 2 | $112,220 |
| Cambridge | MA | 2 | $119,250 |
| Mountain View | CA | 1 | $130,000 |
| Pleasanton | CA | 1 | $120,000 |
| Boston | MA | 1 | $95,000 |
| South San Francisco | CA | 1 | $142,700 |
| CAMBRIDGE | MA | 1 | $145,000 |
| Doylestown | PA | 1 | $130,000 |
These roles are variations of Scientist II with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Scientist II | 24 | $112,471 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 4 | $115,154 | 75.0% |
| 2022 | 5 | $130,000 | 100.0% |
| 2023 | 3 | $120,000 | 100.0% |
| 2024 | 2 | $106,208 | 100.0% |
| 2025 | 2 | $131,389 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Novartis Institutes for BioMedical Research, Inc. | 3 | $117,416 | 100.0% |
| Schrodinger Inc. | 2 | $119,925 | 100.0% |
| IGM Autoimmunity and Inflammation, Inc | 2 | $130,000 | 100.0% |
| Carmine Therapeutics, Inc. | 2 | $112,220 | 50.0% |
| Lyterian Therapeutics | 1 | $142,700 | 100.0% |